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Neurochemistry and Toxicology:
Overview
by Terri Damstra*
We have witnessed a tremendous increase in our knowledge of the molecular and biochemical
mechanisms which underly the activities of the nervous system. Such knowledge is essential in order to
determine the basic mechanisms involved in neurotoxic events. An overview of how neurotoxins could
conceivably interfere with some basic neurochemical processes is presented, along with a specific example
of how an understanding of such processes can contribute to the detection of neurotoxicity and to the
development of predictive testing techniques.
Introduction
Conceptually, the assessment ofthe potential ad-
verse effects of toxic agents on the central (CNS)
and peripheral (PNS) nervous system, may be di-
vided into several components. Those of primary
concern at this symposium are: (1) the detection of
neurotoxicity, (2) the determination of the basic
biochemical and physiological mechanisms in-
volved, and (3) the development of predictive test-
ing techniques. Some ofthe other clinical aspects of
neurotoxicity such as prevention and treatment, are
obviously very important but are not the major
focus ofthis conference. The discussions ofthe first
twodays have focused mainly onthe behavioral and
morphological approaches and methodologies
available for detecting and predicting neurotoxic
effects. Today's session will consider the role of
neurochemical approaches. The ultimate, unifying
objective ofneurochemistry is the elucidation ofthe
basic molecular and biochemical mechanisms un-
derlying neural functions or associated with alter-
ation of these functions. It is through the determi-
nation of such mechanisms that neurochemical ap-
proaches can probably best contribute to the overall
assessment of neurotoxicity. Although our knowl-
edge ofthe biochemical activities subserving neural
functions is still very rudimentary, enormous prog-
ress has been made in this area during the past half
century.
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Neurochemical Approaches
It has already been pointed out during this con-
ference that toxic agents can affect the CNS and
PNS in a variety of ways. Some agents act directly
on the nervous system, whereas others disturb non-
neuronal processes which may indirectly affect the
CNS and/or PNS. Most of these toxins interfere
with some biochemical system, either through gen-
eral or specific mechanisms. Many toxic responses
are the result of enzyme inhibition by allosteric,
competitive, or noncompetitive mechanisms.
Other, more generalized toxic effects may result
from such processes as anoxia or protein denatura-
tion. Neurotoxins can cause disturbances in the
cerebrospinal fluid- and blood brain barriers; inter-
fere with neuronal energy metabolism or the
biosynthetic pathways of carbohydrates, lipids,
nucleic acids, and proteins; alter the cellular per-
meability to ions; affect neurotransmitter synthesis,
storage, release, and uptake; or inhibit neurosecre-
tory processes. Such changes can occur in finely
localized regions, in particular cell types (astro-
cytes, neurons, oligodendrocytes, etc.) and in
specific subcellular organelles. Thus, the dimen-
sions and complexity of the tasks confronting re-
searchers attempting to determine the biochemical
mechanisms underlying neurotoxicity are tremen-
dous, and the approaches selected will depend to a
large extent on the physical and chemical properties
of the particular toxic substances under considera-
tion.
One primary concern of neurochemists must be
to correlate neurochemical alterations with struc-
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even though such correlations are difficult to estab-
lish because ofthe potent compensatory capabilities
ofthe nervous system. Many attempts at such cor-
relations have focused on the role of putative
chemical transmitter substances in the nervous
system. This orientation does not imply that other
aspects ofneural biochemistry are unimportant, but
studies on chemicaltransmission have provided one
convenient way of exploring the interrelationships
between neurochemical events and behavior. Fur-
thermore, sophisticated methodologies are avail-
able and an extensive background literature on the
basic mechanisms involved in chemical transmis-
sion already exist. Several ofthese will be discussed
in the presentations of this session. I would like to
give a brief overview of how neurotoxins might
interfere with chemical transmission in the nervous
system by simplifying and conceptualizing some of
the events involved in this process. Comprehensive
descriptions of chemical transmission mechanisms
can be found in many reviews (1-6).
Figure 1 is a schematic presentation of a pre-
synaptic neuron consisting ofa cell body (I), myeli-
nated axon (II), and nerve terminal (III); and of a
postsynaptic membrane receptor region (IV).
Transmitter-forming enzymes along with other
proteins and cellular constituents are synthesized in
the cell body (I) under control of the nucleus (N).
After compartmentalization, the synthesized ma-
terial (S) enters the axon (II) probably under the
control ofthe Golgi apparatus (G). These materials,
along with structural organelles, are then delivered
to the presynaptic endings by the process of axo-
plasmic transport. Some compounds also supply the
axolemma (A) and the myelin sheath, represented
by parallel horizontal lines. Retrograde transport is
indicated by the arrow towards the cell body. The
axonal transport system utilizes specific proteins,
microtubules (M), neurofilaments (N), and ATP.
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FIGURE 1. Schematic presynaptic neuron and postsynaptic re-
ceptor region.
Upon entry of the necessary precursors from the
extracellular environment surrounding these pre-
synaptic endings (III), transmitters are synthesized
and packaged into pre-existing vesicles (V), along
with ATP and proteins (e.g., vesiculin) which serve
as "binders" for transmitter molecules. Upon
stimulation ofthe presynaptic nerve ending, there is
an influx ofcalcium ions, and the vesicles nearest to
the membrane surface fuse to the surface. The
neurotransmitter (NT) is then released into the
synaptic cleft, a region several hundred Angstroms
wide, viathe process ofexocytosis. The release ofa
neurotransmitter initiates a complex sequence of
postsynaptic events. The transmitter impinges on
the postsynaptic cell by binding to a particular
membrane receptor (R). Excess transmitter may be
rapidly inactivated via reuptake mechanisms, en-
zymatic degradation, or metabolic inactivation. Re-
ceptor binding results in an activation of a specific
adenyl cyclase (AC) enzyme, which increases the
production ofcyclic AMP (CAMP). Cyclic AMP in
turn activates specific protein kinases allowing the
phosphorylation of specific protein substrates
(PPO4). It is thought that upon phosphorylation,
conformational changes occur in membrane pro-
teins which may produce changes in ion per-
meabilities. The resultant ionic fluxes may cause
hyperpolarization or depolarization of the post-
synaptic cells.
Phosphorylation of synaptic proteins may also
lead to modifications ofthe functional properties of
the postsynaptic membrane at other sites and thus
lead to changes in interneuronal conductivity. This
sequence of activity can be terminated through en-
zymatic dephosphorylation ofproteins and cleavage
of cyclic nucleotides.
Many other factors are known or hypothesized to
modulate this series of events. For example, cyclic
GMP may have effects on tissue protein phos-
phorylation that are opposite to that ofcyclic AMP.
Neurohormones can interact with cell surface re-
ceptors (P) and cause a variety of cellular and nu-
clear events, including the phosphorylation of nu-
clear proteins. The latter may alter transcription
processes, and thus produce long-term changes in
the properties ofneurons. These simplified descrip-
tions of synaptic transmission barely begin to
scratch the surface of the complex molecular be-
havior of nerve tissue.
Since there is no evidence to the contrary, it must
be assumed that neurotoxins can interfere at any
stage with the above processes. The research to
date has examined only a few ofthese events. Most
studies have concentrated heavily on assays of the
steady-state levels oftransmitters and the activities
ofenzymes responsible for transmitter synthesis or
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rates, and synaptic uptake and release mechanisms
have also been studied. Consequently, our knowl-
edge of the primary biochemical events associated
with neurotoxicity is very limited. More com-
prehensive and diverse approaches are necessary.
Some ofthese approaches will be reviewed and up-
dated in the subsequent presentations.
Predictive Testing
I would like to conclude with an example ofhow
our knowledge of basic neurochemical events may
contribute to the detection ofneurotoxicity and lead
to the development ofpredictive testing techniques.
It has long been known that organophosphorus in-
secticides can cause acute central CNS effects by
inhibiting the crucial nervous system enzyme
acetylcholinesterase. The primary neurochemical
event associated with such inhibition has been
shown to be the phosphorylation ofa serine residue
within the active site of this cholinesterase (7). In
addition to such central cholinergic effects, some
organophosphates may produce degenerative
changes in the central and peripheral nervous sys-
tem, which ultimately result in a sensory-motor
neuropathy, but this neuropathy does not manifest
itself until several days or weeks after exposure.
This delayed neurotoxicity is seen in mammals, in-
cluding man, and is especially pronounced in chick-
ens; however, not all species are equally suscepti-
ble, and it is not readily induced in rodents. Adults
are more susceptible than younger animals. This le-
sion is not primarily a function of the central
cholinergic response, since most organophosphates
are inactive. Indeed, protection against the delayed
neurotoxic effects can sometimes be obtained with
other esterase inhibitors. Some elegant studies,
mainly by Johnson et al. (8-10), have shown that the
neuropathy-inducing organophosphates interfere in
a specific way with a characteristic membrane-
bound nerve cell protein. Although the precise cel-
lular location of this protein remains unknown, it
has been isolated and characterized as "neurotoxic
esterase." Neurotoxic esterase is present in various
brain regions, and in spinal cord, and sciatic nerve.
It has been found in all species examined, including
the nonsusceptible ones. It accounts for about 5%
of total brain cholinesterase activity. Extensive in-
vestigations on the role of neurotoxic esterase in
organophosphorus-induced nerve degeneration
support the following sequence of events.
Organophosphates can inhibit neurotoxic es-
terase by phosphorylating a serine residue within its
active site [step 1, Eq. (1)]. Subsequent to this
reaction, one of the R groups may in some cases
undergo cleavage by hydrolysis, yielding an inac-
tive enzyme with a stable ionized acidic group on
the esteratic site (step 2).
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The organophosphorus compounds that are capable
of producing such ionized complexes are the ones
that can cause subsequent nerve degeneration, pre-
sumably by upsetting some normal process which
ultimately results in neuropathy. Reactions of
neurotoxic esterase with other organophosphates
(phosphinates and carbamates) result in stable
R-P bonds; no ionized group is formed, and
nerve degeneration does not occur. Inhibition of
neurotoxic esterase by these compounds actually
may protect against the effects that might result
from subsequent administration of the
neuropathy-inducing compounds. Thus the delayed
neuropathy depends on the nature of the R group
and is secondary to the inhibition of "neurotoxic
esterase." Although enzyme inhibition occurs im-
mediately after exposure and activity returns to
normal (due to resynthesized enzyme) after several
hours, the neuropathy is not clinically detectable
until 10-20 days later. Once exposure has occurred,
there is presently no way ofpreventing the onset of
neuropathy. The sequence of biochemical events
beginning with the phosphorylation of neurotoxic
esterase and ending in axonal degeneration has not
been elucidated, but should have high priority since
it may shed light on the development of other
neuropathies, although at the present time there ap-
pears to be no common mechanism.
The isolation and characterization of neurotoxic
esterase has made it feasible to developin vitro tests
for determining whether a compound has delayed
neuropathy inducing properties. In addition,
species variation, structure-activity relationships,
chronic dosing effects, and potential preventive
measures could also be evaluated in this system.
Thus we have a concrete example of the role that
basic neurochemical studies may play in the de-
velopment of predictive testing techniques for hu-
mans.
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Science historians indicate that there is often a
20-year lag between the inception ofadiscipline and
its practical applications. Neurochemistry has
clearly emerged as a distinct discipline during the
past decades, but we are only beginning to witness
some of its breakthroughs with respect to tox-
icology. The "black box" is turning grey.
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